Therapy Areas: Infectious Diseases
Merck KGaA to acquire JSR Life Sciences chromatography business to expand Protein A capabilities
15 October 2025 - German science and technology company Merck KGaA (ETR:MRK) announced on Wednesday that its Life Science business, which operates as MilliporeSigma in the US and Canada, has signed a ...
60 Degrees reports first patient has tested negative for babesiosis in tafenoquine study
15 October 2025 - US-based pharmaceutical company 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW), a developer of medicines for vector-borne disease, said on Wednesday that the first patient to...
INOVIO announces inducement grant to new employee
3 October 2025 - INOVIO (NASDAQ:INO), a US-based biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and i...
Hologic receives FDA clearance and CE mark for new gastrointestinal bacterial assays
2 October 2025 - Women's health company Hologic Inc (Nasdaq:HOLX) on Thursday announced US FDA 510(k) clearance and European CE marking for its Panther Fusion Gastrointestinal (GI) Bacterial and ...
Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m
...
LakeShore Biopharma receives Nasdaq delisting determination letter
15 September 2025 - LakeShore Biopharma Co, Ltd (Nasdaq: LSB), a China-based global biopharmaceutical company that is involved in discovering, developing, manufacturing, and delivering new generations...